← Back to Search

BP REACH Intervention for High Blood Pressure (BP-REACH Trial)

N/A
Recruiting
Led By Alejandra Casillas, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction
Be older than 18 years old
Must not have
Age < 35 years
Only speaks a language other than English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial is testing a team-based program to help reduce blood pressure for heart attack and stroke survivors. Participants get follow up with a pharmacist, education, and monthly phone calls from a health coach.

Who is the study for?
This trial is for English or Spanish speakers over 35 years old with high blood pressure (SBP ≥ 130 mm Hg) who have had a stroke or heart attack and are patients at specific LA medical centers. It's not for those who can't consent due to conditions like dementia.
What is being tested?
The BP REACH Intervention, a team-based program involving pharmacists and health coaches, aims to lower blood pressure in people with past strokes or heart attacks. It will be compared to usual care over a period of 12 months.
What are the potential side effects?
Since the intervention involves lifestyle coaching and medication management rather than new drugs, side effects may be minimal but could include potential stress from lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stroke or heart attack and am a patient at one of the specified medical centers.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 35 years old.
Select...
I speak a language other than English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Systolic blood pressure (SBP) mmHG
Secondary study objectives
BMI (body mass index)
Diet
HgbA1c (hemoglobin A1C)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants follow the intervention protocol, including receiving educational materials, a home blood pressure monitor, coaching calls from BP REACH coaches and medication management from a pharmacist.
Group II: Usual CareActive Control1 Intervention
Participants receive the usual care received by patients of the medical center

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
936 Previous Clinical Trials
1,612,481 Total Patients Enrolled
University of California, Los AngelesOTHER
1,554 Previous Clinical Trials
10,263,114 Total Patients Enrolled
University of California, IrvineOTHER
559 Previous Clinical Trials
1,929,008 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05937685 — N/A
High Blood Pressure Research Study Groups: Usual Care, Intervention
High Blood Pressure Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05937685 — N/A
Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05937685 — N/A
~567 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top